title: Does IRISIN Have a BRITE Future as a Therapeutic Agent in Humans?
abstract: The epidemic of obesity has contributed to the rapid rise in comorbid conditions such as cardiovascular disease, type 2 diabetes, sleep apnea, and hypertension among others. Therefore, there is a critical need to develop therapeutic strategies to reduce the prevalence of the disease. Skeletal muscle cells secrete signaling cytokines/peptides (referred to as myokines) that act in autocrine, paracrine, and endocrine fashion. Myokines have been hypothesized to contribute to the immediate and chronic benefits of exercise and may thus serve as attractive therapeutic agents for the treatment of obesity. The recent discovery of the irisin, a proposed myokine, has gained much attention over the last two years as a potential therapeutic agent. Preliminary studies demonstrated that irisin has the potential to induce "browning" of white adipocytes in mice. If these findings in mice could be translated to humans, irisin could be a potential therapeutic agent for the treatment of obesity. Limitations with the available antibodies, however, have raised concerns regarding the detectability of irisin in circulation. Moreover, the gene encoding irisin, FNDC5, is expressed robustly not only in muscle but also in various white adipose tissues (WAT) in humans, raising the possibility for increased thermogenesis through autocrine mechanisms. Here we will discuss the browning of WAT, the discovery of irisin, and its potential role in improving metabolic health in humans.
authors.affiliation: Department of Gastroenterology, Geisinger Medical Center, Danville, PA USA ; Geisinger Obesity Institute, Geisinger Medical Center, Danville, PA USA ; Weis Center for Research, Geisinger Medical Center, Danville, PA USA ; Geisinger Obesity Institute, Geisinger Health System, 100 N. Academy Ave, Danville, PA 17868 USA.
authors.forename: Brian A
authors.initials: BA
authors.lastname: Irving
authors.affiliation: Department of Gastroenterology, Geisinger Medical Center, Danville, PA USA ; Geisinger Obesity Institute, Geisinger Medical Center, Danville, PA USA.
authors.forename: Christopher D
authors.initials: CD
authors.lastname: Still
authors.affiliation: Department of Gastroenterology, Geisinger Medical Center, Danville, PA USA ; Geisinger Obesity Institute, Geisinger Medical Center, Danville, PA USA ; Weis Center for Research, Geisinger Medical Center, Danville, PA USA.
authors.forename: George
authors.initials: G
authors.lastname: Argyropoulos
keywords: Adaptive thermogenesis; Adipokines; Beige adipose tissue; Brite adipocytes; Brown adipose tissue; FNDC5; Human; Irisin; Metabolism; Mice; Mitochondria; Myokines; Physical activity; Skeletal muscle; UCP1; Uncoupling; Weight loss; White adipose tissue